Loading
Diabetes and Associated Disorders · Journal article
Journal of Virology · September 10, 2026
Encouraging direction, but not yet definitive.
This observational cohort study identifies HCV-specific IFN-γ-producing T cell frequency and neutralizing antibody responses to difficult-to-neutralize isolates as independent correlates of long-term protective immunity against reinfection in people who inject drugs. The findings suggest both arms of adaptive immunity contribute distinctly to protection, but the small sample size and inability to distinguish causation from association limit immediate clinical application.
Observational prospective cohort study with longitudinal analysis and multivariate random forest analysis. People who inject drugs with documented spontaneous clearance of acute primary HCV infection, stratified by reinfection status during high-risk exposure follow-up.. Compared with: FOR versus reinfected groups; comparison of T cell and antibody responses as independent correlates.. n = 56.
Among 34 FOR subjects, 73.5% (n=25) exhibited high frequencies of IFN-γ-producing T cells, while 23.5% (n=8) showed high neutralization breadth or potency Multivariate random forest analysis identified IFN-γ-producing T cell frequency and NAb response against HCVpp 1b58 as significant predictors of protection (P < 0.05) Strong and broad HCV-specific T cell responses were associated with spontaneously cleared infection episodes in subjects with multiple infections
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
These findings provide mechanistic insight into HCV protective immunity that could inform vaccine design, suggesting target antigens should focus on inducing both robust T cell responses and antibodies against difficult-to-neutralize strain variants. However, the small sample size and observational design mean these correlations require confirmation in prospective studies before clinical implementation.
A well-designed observational cohort study with multivariate analysis identifying independent correlates of long-term HCV reinfection protection, but limited by small sample size, lack of intervention, and reliance on a high-risk population that may not generalize.
As stated by the source record.
Quoted from the source exactly as published.
These findings provide mechanistic insight into HCV protective immunity that could inform vaccine design, suggesting target antigens should focus on inducing both robust T cell responses and antibodies against difficult-to-neutralize strain variants. However, the small sample size and observational design mean these correlations require confirmation in prospective studies before clinical implementation.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
ABSTRACT Virus-specific T cells and broadly neutralizing antibodies (NAbs) are associated with spontaneous clearance of acute primary hepatitis C virus (HCV) infection and reinfection. Following spontaneous clearance, HCV-specific memory T cells are long-lived, but NAbs are less durable. How these two arms contribute to long-term protective immunity upon re-exposure is unknown. Herein, we compared the magnitude and breadth of memory HCV-specific T cells and NAbs in a cohort of HCV-spontaneously resolved people who inject drugs with high-risk exposure to the virus but who remained free of observed reinfections (FOR, n = 34) or who got reinfected ( n = 22). Among FOR, 73.5% ( n = 25) exhibited high frequencies of gamma interferon (IFN-γ)-producing T cells, while 23.5% ( n = 8) showed high neutralization breadth (>25% neutralization of HCV pseudoparticles [HCVpp]) and/or potency (geometric mean neutralization >50% against seven HCVpp). Notably, some subjects had detectable NAbs several years after clearance. Multivariate random forest analysis demonstrated that the frequency of IFN-γ-producing T cells and the NAb response against only one difficult-to-neutralize HCVpp (1b58) were significant predictors of protection against reinfection ( P < 0.05). Longitudinal analysis of the immune response in subjects with multiple episodes of infection showed that strong and broad HCV-specific T cell responses were associated with spontaneously cleared episodes. In contrast, NAbs did not protect from chronicity upon re-exposure in the absence of memory T cells, or if they were unable to recognize the infecting virus due to imprinting by strains of the previous episodes. In conclusion, T cell responses and NAbs targeting specific isolates are independent predictors of long-term protective immunity against HCV. IMPORTANCE Hepatitis C virus (HCV) is a blood-borne virus that disproportionately affects people who inject drugs. Most HCV infections become persistent, leading to liver fibrosis and cancer. Although effective antiviral therapies are available, around 50 million people remain persistently infected with HCV and can transmit the virus. Currently, there is no available vaccine to control the spread of HCV. However, around one in four people infected can naturally clear the virus, becoming partially protected upon re-exposure, suggesting it is possible to develop a vaccine that induces similar protection. In this study, we investigated the contribution of T cells and neutralizing antibodies to protection against observed reinfection in a cohort of people who inject drugs and have naturally cleared HCV, yet remain at high-risk exposure. Our findings suggest that strong T cell responses and neutralizing antibodies targeting hard-to-neutralize isolates could predict protective immunity upon reinfection.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.